1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Syndactyly, Type I: new trials by email Literature Review of Syndactyly, Type I trials Research Report on Syndactyly, Type I
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor AFNT-211 - Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Active not recruiting | Affini-T Therapeutics, Inc. | 100 | 2024-03-06 | 2025-07-30 |
Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1)
Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Rectal Diseases (1) · Respiratory Tract Diseases (1)
Affini-T Therapeutics, Inc. (1)
United States (1)